Trial Outcomes & Findings for Scalpel vs Diathermy in Repeat Cesarean Delivery (NCT NCT02493608)

NCT ID: NCT02493608

Last Updated: 2020-03-24

Results Overview

Time to make an abdominal wall incision from skin to rectus fascia.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

100 participants

Primary outcome timeframe

during surgery

Results posted on

2020-03-24

Participant Flow

4 were excluded from due to prior midline vertical skin incision.

Participant milestones

Participant milestones
Measure
Scalpel Group
Scalpel is the device used to make abdominal wall incision in this group of patient. scalpel: used to cut the abdominal wall.
Diathermy Group
In this study group, abdominal wall incisions are made with diathermy which is a electrosurgical instrument. Diathermy: Diathermy used to cut , coagulate the tissue
Overall Study
COMPLETED
48
48
Overall Study
STARTED
48
48
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Scalpel Group
n=48 Participants
Scalpel is the device used to make abdominal wall incision in this group of patient. scalpel: used to cut the abdominal wall.
Diathermy Group
n=48 Participants
In this study group, abdominal wall incisions are made with diathermy which is a electrosurgical instrument. Diathermy: Diathermy used to cut , coagulate the tissue
Total
n=96 Participants
Total of all reporting groups
Age, Continuous
26.9 years
STANDARD_DEVIATION 5.1 • n=48 Participants
28.4 years
STANDARD_DEVIATION 5.3 • n=48 Participants
NA years
STANDARD_DEVIATION NA • n=96 Participants
Sex: Female, Male
Female
48 Participants
n=48 Participants
48 Participants
n=48 Participants
96 Participants
n=96 Participants
Sex: Female, Male
Male
0 Participants
n=48 Participants
0 Participants
n=48 Participants
0 Participants
n=96 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Gravida
3.1 Pregnancies
STANDARD_DEVIATION 1.1 • n=48 Participants
3.5 Pregnancies
STANDARD_DEVIATION 1.7 • n=48 Participants
NA Pregnancies
STANDARD_DEVIATION NA • n=96 Participants
Para
1.7 births
STANDARD_DEVIATION 0.8 • n=48 Participants
1.7 births
STANDARD_DEVIATION 0.8 • n=48 Participants
NA births
STANDARD_DEVIATION NA • n=96 Participants
Weeks of Gestation
38.7 Weeks
STANDARD_DEVIATION 0.7 • n=48 Participants
38.4 Weeks
STANDARD_DEVIATION 1.9 • n=48 Participants
NA Weeks
STANDARD_DEVIATION NA • n=96 Participants
Height
161.5 Centimeters
STANDARD_DEVIATION 7.5 • n=48 Participants
160 Centimeters
STANDARD_DEVIATION 7.4 • n=48 Participants
NA Centimeters
STANDARD_DEVIATION NA • n=96 Participants
Weight
85.3 kg
STANDARD_DEVIATION 17.9 • n=48 Participants
86.9 kg
STANDARD_DEVIATION 15.1 • n=48 Participants
NA kg
STANDARD_DEVIATION NA • n=96 Participants
BMI
32.7 kg/m^2
STANDARD_DEVIATION 6.4 • n=48 Participants
34.1 kg/m^2
STANDARD_DEVIATION 5.7 • n=48 Participants
NA kg/m^2
STANDARD_DEVIATION NA • n=96 Participants
Number of C-Sections
1.5 number of C-sections
STANDARD_DEVIATION 0.7 • n=48 Participants
1.7 number of C-sections
STANDARD_DEVIATION 0.7 • n=48 Participants
NA number of C-sections
STANDARD_DEVIATION NA • n=96 Participants
Type of Anesthesia
Spinal
44 Participants
n=48 Participants
46 Participants
n=48 Participants
90 Participants
n=96 Participants
Type of Anesthesia
Epidural
4 Participants
n=48 Participants
2 Participants
n=48 Participants
6 Participants
n=96 Participants
Type of Surgery
Elective
41 Participants
n=48 Participants
38 Participants
n=48 Participants
79 Participants
n=96 Participants
Type of Surgery
Non-Elective
7 Participants
n=48 Participants
10 Participants
n=48 Participants
17 Participants
n=96 Participants

PRIMARY outcome

Timeframe: during surgery

Time to make an abdominal wall incision from skin to rectus fascia.

Outcome measures

Outcome measures
Measure
Scalpel Group
n=48 Participants
Scalpel is the device used to make abdominal wall incision in this group of patient. scalpel: used to cut the abdominal wall.
Diathermy Group
n=48 Participants
In this study group, abdominal wall incisions are made with diathermy which is a electrosurgical instrument. Diathermy: Diathermy used to cut , coagulate the tissue
Incision Time .
271.5 Seconds
Standard Deviation 109.31
188.17 Seconds
Standard Deviation 120.03

SECONDARY outcome

Timeframe: Post Operative Day (POD) 1 and Day 2

Done by VAS scale. Visual Analog Scale to measure pain. Scale range from 0 to 10 with higher values indicating worse pain.

Outcome measures

Outcome measures
Measure
Scalpel Group
n=48 Participants
Scalpel is the device used to make abdominal wall incision in this group of patient. scalpel: used to cut the abdominal wall.
Diathermy Group
n=48 Participants
In this study group, abdominal wall incisions are made with diathermy which is a electrosurgical instrument. Diathermy: Diathermy used to cut , coagulate the tissue
Post Operative Pain
POD 1
1.9 units on a scale
Standard Deviation 2.6
2.6 units on a scale
Standard Deviation 3.1
Post Operative Pain
POD 2
3.2 units on a scale
Standard Deviation 3.3
2.9 units on a scale
Standard Deviation 3.2

SECONDARY outcome

Timeframe: Blood lost during incision/surgery

Blood lost during incision/surgery

Outcome measures

Outcome measures
Measure
Scalpel Group
n=48 Participants
Scalpel is the device used to make abdominal wall incision in this group of patient. scalpel: used to cut the abdominal wall.
Diathermy Group
n=48 Participants
In this study group, abdominal wall incisions are made with diathermy which is a electrosurgical instrument. Diathermy: Diathermy used to cut , coagulate the tissue
Blood Loss
15.98 grams
Standard Deviation 14.4
11.11 grams
Standard Deviation 15.43

Adverse Events

Scalpel Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Diathermy Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Chadley Copeland

Texas Tech Health Sciences Center

Phone: 8067434752

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place